drugset
drugset / Trial / NCT02386462

Determine the ED50 of Dexmedetomidine to Facilitate LMA Insertion During Anaesthesia Induction

NCT02386462 ↗

Phase 4 Unknown 30 enrolled Guangzhou General Hospital of Guangzhou Military Command
NaSingle-groupOpen-labelTreatment

Summary

Dexmedetomidine can be used as a co-induction agent to facilitate laryngeal mask airway (LMA) insertion with minimal effect on respiratory function. The purpose of the study was to determine the median effective dose (ED50) of dexmedetomidine to facilitate LMA insertion during anaesthesia induction with propofol 2.0 mg/kg.

Timeline

Start
2014-11
Primary completion
2015-04
Completion
2015-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexmedetomidine Other / unclassified 1 ug/kg —
Background Propofol Small molecule 2 mg/kg —

Indications

No indication recorded.